Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes

NCT00807092 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart 30
DRUG: biphasic human insulin 30
DRUG: metformin

Sponsor

Novo Nordisk A/S